ProAssurance Stock (NYSE:PRA), Trade Ideas

ProAssurance

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AFIB

AFRM

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ASLE

ASRT

ASTR

ATRA

BILL

Bakkt Holdings, Inc. Class A Common Stock

BKKT

CART

CCCS

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CDLX

CFRX

CIFR

CLMT

COOK

DNUT

FOSL

FREY

GDRX

HNST

HTCR

IKNA

Intelligent Bio Solutions Inc. - Common Stock

INBS

INFN

INSE

JRVR

LAZR

MARA

MODG

MYGN

NVTA

PAHC

PUBM

RAMP

RIOT

RMCO

RVNC

SLGC

SNES

SPCE

TAST

Tempest Therapeutics, Inc. - Common Stock

TPST

WLDS

Gainers


	Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.


Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Long Ideas

Pre-Market Outlook

COFS

EVBN

HWBK

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.

Top 5 Financial Stocks You&#39;ll Regret Missing This Quarter

ABNB

ADXN

ALTO

AMPL

ANGI

AXON

BBLN

BHAT

BHIL

BJDX

CANO

CARG

CELH

CHSN

COHR

COMP

CRCT

CTIC

CTKB

CUEN

GRWG

HCDI

KIND

LPRO

LPSN

LTRY

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

MESA

MNKD

MOBQ

MVST

OKYO

RETA

RVSN

RYAM

SFWL

SILK

SPRY

STIX

STSS

TBLA

TWLO

UFAB

UPST

VYNT

WETG

XMTR

ZFOX

Gainers


	Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.


Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

ProAssurance Corp

PRA Group Inc

PRODUCTIVITY TECHS CORP by Productivity Technologies Corp.

Productivity Technologies Corp

Northern Lights Fund Trust III PlanRock Alternative Growth ETF

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicines Inc

NEOS ETF Trust FIS Christian Stock Fund

<p>In the last three months, 5 analysts have published ratings on ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.4, a high estimate of $24.00, and a low estimate of $14.00. This current average has decreased by 1.77% from the previous average price target of $19.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713211302_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of ProAssurance among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Carletti</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$22.00</td>
<td>-</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Carletti</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$14.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Carletti</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ProAssurance. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ProAssurance compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of ProAssurance's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of ProAssurance's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PRA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on ProAssurance analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>All You Need to Know About ProAssurance</h2>
<p>ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&amp;C activities, followed by Worker's Compensation.</p>
<h3>Key Indicators: ProAssurance's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Challenges:</strong> ProAssurance's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately <strong>-0.05%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>2.16%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> ProAssurance's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>0.6%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> ProAssurance's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.11%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.4</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

ProAssurance Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

<p>JMP Securities  analyst Matthew Carletti   reiterates ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Market Outperform and maintains $22 price target.</p>


Price Target

Reiteration

JMP Securities Reiterates Market Outperform on ProAssurance, Maintains $22 Price Target

<p>Piper Sandler  analyst Paul Newsome   maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Overweight and maintains $15 price target.</p>


Piper Sandler Maintains Overweight on ProAssurance, Maintains $15 Price Target

<p><a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. </p>
<h3>Gainers</h3>
<ul>
<li><strong>Huize Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUIZ#NASDAQ">HUIZ</a>) shares rose 15.85% to $0.76 during Tuesday's regular session. Huize Holding's stock is trading at a volume of 86.0K shares as of 13:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $33.2 million. </li>
<li><strong>Marpai</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) stock rose 12.27% to $2.2. As of 13:40 EST, Marpai's stock is trading at a volume of 639.4K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.6 million. </li>
<li><strong>Universal Insurance Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UVE#NYSE">UVE</a>) stock increased by 7.11% to $21.0. Trading volume for this security as of 13:40 EST is 223.0K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $567.7 million. </li>
<li><strong>Fanhua</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANH#NASDAQ">FANH</a>) stock rose 5.1% to $5.79. Trading volume for Fanhua's stock is 159.2K as of 13:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $339.8 million. </li>
<li><strong>Kingstone Companies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) shares moved upwards by 4.9% to $3.9. Trading volume for this security as of 13:40 EST is 21.1K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $41.7 million. </li>
<li><strong>American Coastal</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) shares rose 3.76% to $10.48. Trading volume for this security as of 13:40 EST is 252.1K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $467.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Lemonade</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) shares fell 3.46% to $16.79 during Tuesday's regular session. As of 13:40 EST, Lemonade's stock is trading at a volume of 1.1 million, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion. </li>
<li><strong>Hippo Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) shares decreased by 2.51% to $17.93. Trading volume for Hippo Holdings's stock is 39.0K as of 13:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $447.0 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li><strong>HCI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCI#NYSE">HCI</a>) shares fell 1.87% to $110.49. As of 13:40 EST, HCI Group's stock is trading at a volume of 113.0K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q4 earnings report came out 3 days ago. </li>
<li><strong>Root</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares decreased by 1.86% to $41.86. As of 13:40 EST, Root's stock is trading at a volume of 515.5K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $625.7 million. </li>
<li><strong>United Fire Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFCS#NASDAQ">UFCS</a>) shares fell 1.82% to $22.16. The current volume of 20.0K shares is 0% of United Fire Gr's average full-day volume over the last 100 days (last updated at 13:40 EST). The company's market cap stands at $570.5 million. </li>
<li><strong>ProAssurance</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock decreased by 1.76% to $12.05. Trading volume for this security as of 13:40 EST is 61.4K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $625.4 million. </li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ACIC

FANH

HIPO

HUIZ

KINS

LMND

MRAI

ROOT

UFCS

Insurance Stocks Moving In Tuesday's Intraday Session

<p>Across the recent three months, 4 analysts have shared their insights on ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $18.75, a high estimate of $24.00, and a low estimate of $14.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.25%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1709568105_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>A clear picture of ProAssurance's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Matthew Carletti</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$14.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Carletti</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to ProAssurance. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ProAssurance compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of ProAssurance's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of ProAssurance's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PRA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on ProAssurance analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Delving into ProAssurance's Background</h2>
<p>ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&amp;C activities, followed by Worker's Compensation.</p>
<h3>ProAssurance's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, ProAssurance faced challenges, resulting in a decline of approximately <strong>-0.05%</strong> in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> ProAssurance's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>2.16%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> ProAssurance's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>0.6%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> ProAssurance's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.11%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> ProAssurance's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.4</strong>.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Demystifying ProAssurance: Insights From 4 Analyst Reviews

<p>Piper Sandler  analyst Paul Newsome   maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Overweight and lowers the price target from $16 to $15.</p>


Piper Sandler Maintains Overweight on ProAssurance, Lowers Price Target to $15

<p>JMP Securities  analyst Matthew Carletti   maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Market Outperform and lowers the price target from $24 to $22.</p>


JMP Securities Maintains Market Outperform on ProAssurance, Lowers Price Target to $22

<p>Truist Securities  analyst Mark Hughes   maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Hold and lowers the price target from $15 to $14.</p>


Truist Securities Maintains Hold on ProAssurance, Lowers Price Target to $14

<p><a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. </p>
<h3>Gainers</h3>
<ul>
<li><strong>Root</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) stock moved upwards by 8.05% to $27.23 during Wednesday's regular session. As of 12:40 EST, this security is trading at a volume of 873.6K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $349.0 million. </li>
<li><strong>Ryan Specialty Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAN#NYSE">RYAN</a>) shares rose 7.49% to $50.78. As of 12:40 EST, this security is trading at a volume of 767.8K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $5.5 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li><strong>Kingstone Companies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) shares increased by 7.04% to $3.8. As of 12:40 EST, this security is trading at a volume of 25.9K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $33.8 million. </li>
<li><strong>Ambac Financial Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBC#NYSE">AMBC</a>) stock moved upwards by 6.52% to $17.62. As of 12:40 EST, this security is trading at a volume of 278.4K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $787.7 million. The company's, Q4 earnings came out yesterday. </li>
<li><strong>Trupanion</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) shares moved upwards by 4.93% to $28.61. As of 12:40 EST, this security is trading at a volume of 456.0K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. </li>
<li><strong>Erie Indemnity</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>) shares moved upwards by 3.97% to $404.81. The current volume of 59.6K shares is 0% of Erie Indemnity's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $20.3 billion. As per the press release, Q4 earnings came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Marpai</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) shares declined by 10.44% to $1.63 during Wednesday's regular session. Marpai's stock is trading at a volume of 70.5K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.9 million. </li>
<li><strong>Maiden Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) shares decreased by 6.26% to $1.2. Maiden Hldgs's stock is trading at a volume of 189.8K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $133.0 million. </li>
<li><strong>Reliance Global Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) stock declined by 5.89% to $0.47. As of 12:40 EST, Reliance Global Group's stock is trading at a volume of 127.0K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.5 million. </li>
<li><strong>FG Finl Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGFPP#NASDAQ">FGFPP</a>) shares declined by 5.6% to $16.53. As of 12:40 EST, this security is trading at a volume of 1.0K shares, making up 0% of its average full-day volume over the last 100 days. </li>
<li><strong>Hippo Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) stock decreased by 5.01% to $13.68. Trading volume for Hippo Holdings's stock is 194.0K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $325.8 million. </li>
<li><strong>ProAssurance</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) shares fell 4.45% to $12.47. ProAssurance's stock is trading at a volume of 122.9K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $665.1 million. The company's, Q4 earnings came out yesterday. </li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AMBC

ERIE

FGFPP

MHLD

RELI

RYAN

TRUP

Insurance Stocks Moving In Wednesday's Intraday Session

<p><strong>ProAssurance</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:15 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>ProAssurance missed estimated earnings by -183.0%, reporting an EPS of $-0.05 versus an estimate of $0.06.</p>
<p>Revenue was down $10.91 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed on EPS by $0.23 which was followed by a 21.0% drop in the share price the next day.</p>
<p>Here's a look at ProAssurance's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2023</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.16</td>
<td>0.10</td>
<td>0.19</td>
<td>0.13</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.07</td>
<td>0.16</td>
<td>-0.15</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>310.74M</td>
<td>236.75M</td>
<td>343.55M</td>
<td>224.87M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>242.42M</td>
<td>247.86M</td>
<td>239.79M</td>
<td>258.24M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for ProAssurance <a href="https://www.benzinga.com/quote/PRA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

ProAssurance: Q4 Earnings Insights

<p>ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.06 by 183.33 percent.  The company reported quarterly sales of $247.33 million which beat the analyst consensus estimate of $233.09 million by 6.11 percent.  This is a 4.23 percent decrease over sales of $258.24 million the same period last year.</p>


Earnings Beats

Earnings Misses

ProAssurance Q4 2023 Adj EPS $(0.05) Misses $0.06 Estimate, Sales $247.33M Beat $233.09M Estimate